Channelopathies

Long QT Syndrome

  • Long QT Syndrome (LQTS) has multiple genetic origins and is diagnosed primarily using the QTc formula.

    • The cassette formula has proven reliable over time.

    • LQTS is associated with a Gaussian distribution.

    • Symptoms typically manifest in patients with QTc > 470 ms; serious cases have QTc > 500 ms.

    • Patients on therapy (beta blockers, etc.) can show higher QTc.

Stress Testing and ECG

  • When conducting a stress ECG:

    • Perform QT measurement at 4 minutes post-treadmill.

    • Focus on the tangent method to assess the QT interval.

  • Notes on ECG waveforms:

    • Ignore small T waves and U waves; focus on clearer readings.

    • In cases of bundle branch blocks, use the JT interval or subtract QRS duration over 110 ms from QTc.

Diagnosis and Assessment of Long QT

  • Diagnosis of LQTS requires at least Grade 4 symptoms.

  • Various ECG patterns indicate different subtypes of LQTS:

    • Presence of voltage gradient throughout T wave indicates large current with slow resolution, associated with I_KS channels.

    • A balanced isoelectric interval signifies no substantial gradient between currents.

  • Prognostic stratification is critical; some forms have notable implications for treatment.

Types of Long QT Syndrome

  • LQT1: Risk during Exercise (especially swimming) due to catecholamine-induced syncope.

  • LQT2: Triggered by auditory stimuli, common during sleep.

  • LQT3: May lead to events during sleep without prior arousal.

    • Note: Epinephrine challenge test for LQT2 is contraindicated.

Treatment Options

  • Genetic testing is crucial for managing LQS today; beta blockers (Propranolol, Nadolol) are standard treatments.

    • For patients post-cardiac arrest, implants and beta blocker treatment recommended.

  • Left cardiac sympathetic denervation (LCSD):

    • Requires an experienced surgeon to avoid complications.

    • Most patients need left-sided therapy; bilateral is rarely necessary.

Pharmacological Management

  • Mexiletine for specific genotypes:

    • Effective in reducing symptoms in LQT1 and LQT2 patients.

    • Used adjunctively with beta blockers for maximum efficacy.

  • Clinical implications of QT interval monitoring:

    • Risk stratification shows that a QTc of 460 ms correlates with <1% death risk, while >520 ms rises to 6% risk especially in young individuals.

Understanding Channels and Electrophysiology

  • Calcium handling and potassium currents are critical:

    • Excessive calcium release leads to premature ventricular contractions (PVCs) and may cause polymorphic VT.

    • Quinicline to manage CPVT shown to reduce arrhythmic events.

  • The repolarization process involves various ion channels that are integral for maintaining heart rhythm.

Brugada Syndrome and Related Considerations

  • Recognized by significant ST elevation in V1-V2 leads.

  • Genetic abnormalities occur in only 20% of patients.

  • Risk stratification is contingent on both PR interval and QRS width.

  • Not all ECG patterns equate to patient risk; clinical events are more critical for diagnosis.

Conclusion and Future Directions

  • Continued emphasis on genetic testing is critical for both LQTS and Brugada syndrome for effective treatment.

  • Clinical understanding is progressing; however, comprehensive management still relies on established protocols and ongoing research.